[1
]
Department of Dermatology, University Medical Center, Tübingen, Germany. Department
of Internal Medicine II, University Medical Center, Tübingen, Germany.
[2
]
The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[3
]
Memorial Sloan Kettering Cancer Center, New York, New York.
[4
]
Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical
College, New York, New York.
[5
]
Department of Oncology, Service of Medical Oncology, Research Unit 932, Institut Curie,
Paris, France.
[6
]
Department of Oncodermatology, INSERM Research Unit 892, University Hospital, Nantes,
France.
[7
]
Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
[8
]
Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy.
[9
]
Department of Dermatology, University Hospital, West German Cancer Center, University
Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
[10
]
German Cancer Consortium (DKTK), Heidelberg, Germany. Department of Dermatology and
National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
[11
]
Department of Dermatology, University Medical Center, Tübingen, Germany.
[12
]
Departments of Clinical Epidemiology and Applied Biostatistics, University of Tübingen,
Tübingen, Germany.
[13
]
Department of Internal Medicine II, University Medical Center, Tübingen, Germany.
[14
]
Department of Dermatology, University Medical Center, Tübingen, Germany. Department
of Immunology, University of Tübingen, Tübingen, Germany. benjamin.weide@med.uni-tuebingen.de.